Published in Annu Rev Microbiol on January 01, 1997
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med (2006) 11.14
Directed evolution of polymerase function by compartmentalized self-replication. Proc Natl Acad Sci U S A (2001) 8.89
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Viral population estimation using pyrosequencing. PLoS Comput Biol (2008) 5.89
RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A (2001) 5.21
The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci U S A (2004) 4.77
Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev (2008) 4.46
Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A (2002) 4.02
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci U S A (2003) 3.68
Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med (2000) 3.50
Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog (2005) 3.41
Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci U S A (2003) 3.31
Quasispecies theory and the behavior of RNA viruses. PLoS Pathog (2010) 3.19
Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A (1999) 2.85
Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog (2010) 2.80
Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J Virol (1999) 2.78
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (2000) 2.73
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol (2000) 2.68
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol (2003) 2.52
Evolutionary reversals during viral adaptation to alternating hosts. Genetics (2000) 2.49
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog (2009) 2.36
Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J Virol (2005) 2.25
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc Natl Acad Sci U S A (1998) 2.23
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol (2005) 2.17
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions. J Virol (2006) 2.10
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J Virol (2001) 2.08
Molecular machines or pleiomorphic ensembles: signaling complexes revisited. J Biol (2009) 2.07
Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol (2009) 2.06
Arbovirus evolution in vivo is constrained by host alternation. Proc Natl Acad Sci U S A (2008) 2.04
Quasispecies theory in the context of population genetics. BMC Evol Biol (2005) 2.02
The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One (2011) 1.96
Recombination within the pandemic norovirus GII.4 lineage. J Virol (2013) 1.93
Distribution of fitness and virulence effects caused by single-nucleotide substitutions in Tobacco Etch virus. J Virol (2007) 1.90
Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data. Front Microbiol (2012) 1.89
Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev (2007) 1.87
The evolution of RNA viruses: A population genetics view. Proc Natl Acad Sci U S A (2000) 1.84
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J Virol (2001) 1.79
The rate and character of spontaneous mutation in an RNA virus. Genetics (2002) 1.79
Ribavirin causes error catastrophe during Hantaan virus replication. J Virol (2003) 1.78
Phylogeny and geography predict pathogen community similarity in wild primates and humans. Proc Biol Sci (2008) 1.76
Intra- and interhost evolutionary dynamics of equine influenza virus. J Virol (2010) 1.75
Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies. MBio (2017) 1.73
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Estimation of population bottlenecks during systemic movement of tobacco mosaic virus in tobacco plants. J Virol (2003) 1.67
Mechanisms of genetic robustness in RNA viruses. EMBO Rep (2006) 1.67
Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog (2008) 1.65
Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing. BMC Bioinformatics (2011) 1.62
Genetic diversity in RNA virus quasispecies is controlled by host-virus interactions. J Virol (2001) 1.62
Inferring viral quasispecies spectra from 454 pyrosequencing reads. BMC Bioinformatics (2011) 1.62
Analysis of amino acid variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-specific epitopes. PLoS One (2008) 1.61
Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci U S A (2002) 1.60
Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens. Proc Natl Acad Sci U S A (1999) 1.60
Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol (1999) 1.60
Natural selection fails to optimize mutation rates for long-term adaptation on rugged fitness landscapes. PLoS Comput Biol (2008) 1.58
Porcine reproductive and respiratory syndrome virus: description of persistence in individual pigs upon experimental infection. J Virol (2000) 1.55
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol (2000) 1.54
The role of mutational robustness in RNA virus evolution. Nat Rev Microbiol (2013) 1.54
Nonsegmented negative-strand viruses as vaccine vectors. J Virol (2006) 1.53
Mutational fitness effects in RNA and single-stranded DNA viruses: common patterns revealed by site-directed mutagenesis studies. Philos Trans R Soc Lond B Biol Sci (2010) 1.53
The evolutionary and epidemiological dynamics of the paramyxoviridae. J Mol Evol (2008) 1.53
Cooperation between different RNA virus genomes produces a new phenotype. Nat Commun (2012) 1.53
Viral complementation allows HIV-1 replication without integration. Retrovirology (2008) 1.52
Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol (1998) 1.52
Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J Virol (2007) 1.52
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol (2002) 1.52
Role of the human immunodeficiency virus type 1 envelope gene in viral fitness. J Virol (2003) 1.51
Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures. J Virol (2010) 1.51
Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS. J Virol (2002) 1.50
Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. J Mol Evol (2003) 1.49
Is the quasispecies concept relevant to RNA viruses? J Virol (2002) 1.48
Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol (2001) 1.47
Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol (2005) 1.46
Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations. J Virol Methods (2007) 1.43
Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun (2015) 1.40
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J (2009) 1.39
Density-dependent selection in vesicular stomatitis virus. J Virol (2004) 1.37
Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J Virol (1999) 1.37
Vesicular stomatitis virus evolution during alternation between persistent infection in insect cells and acute infection in mammalian cells is dominated by the persistence phase. J Virol (2004) 1.34
Evolutionarily related Sindbis-like plant viruses maintain different levels of population diversity in a common host. J Virol (2000) 1.34
Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33
Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol (2000) 1.32
Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc Natl Acad Sci U S A (2006) 1.32
Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants. J Exp Med (2001) 1.29
Analyses of evolutionary dynamics in viruses are hindered by a time-dependent bias in rate estimates. Proc Biol Sci (2014) 1.28
Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol (2011) 1.28
Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs. J Virol (2010) 1.28
Distinct viral populations differentiate and evolve independently in a single perennial host plant. J Virol (2006) 1.28
Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences. J Clin Microbiol (1999) 1.27
Natural history of highly pathogenic avian influenza H5N1. Virus Res (2013) 1.26
Genetic structure and population variability of tomato yellow leaf curl China virus. J Virol (2007) 1.26
Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol (2012) 1.25
Mechanisms of viral emergence. Vet Res (2010) 1.25
Estimation of the effective number of founders that initiate an infection after aphid transmission of a multipartite plant virus. J Virol (2008) 1.24
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Rapid evolution of RNA viruses. Annu Rev Microbiol (1987) 5.97
Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses. Proc Natl Acad Sci U S A (1968) 5.64
Basic concepts in RNA virus evolution. FASEB J (1996) 3.35
Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J Virol (1999) 2.78
Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells. Biochemistry (1976) 2.69
Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A (1995) 2.60
Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA. J Virol (1986) 2.41
Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv Virus Res (1991) 2.38
Persistent noncytocidal vesicular stomatitis virus infections mediated by defective T particles that suppress virion transcriptase. Proc Natl Acad Sci U S A (1974) 2.34
Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus. Virology (1986) 2.29
Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J Mol Biol (1999) 2.28
Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene (1992) 2.20
Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus. Virology (1972) 2.18
Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J Virol (1995) 2.18
Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell (1984) 2.13
RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol (1990) 2.12
Subclonal components of consensus fitness in an RNA virus clone. J Virol (1994) 2.09
RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis (1994) 2.08
Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 2.05
Evolution of multiple genome mutations during long-term persistent infection by vesicular stomatitis virus. Cell (1979) 2.04
High nucleotide substitution error frequencies in clonal pools of vesicular stomatitis virus. J Virol (1989) 2.04
Ribonucleic acid and protein synthesis in mitotic HeLa cells. J Cell Biol (1965) 1.98
Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol (1989) 1.95
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J Virol (1990) 1.87
Evolution of alphaviruses in the eastern equine encephalomyelitis complex. J Virol (1994) 1.86
Extreme fitness differences in mammalian and insect hosts after continuous replication of vesicular stomatitis virus in sandfly cells. J Virol (1995) 1.84
Synthesis of poly(A) in vitro by purified virions of vesicular stomatitis virus. Nat New Biol (1973) 1.83
Sequence of a RNA templated by the 3'-OH RNA terminus of defective interfering particles of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 1.80
Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus grown in four mammalian cell lines. Proc Natl Acad Sci U S A (1974) 1.78
Synthesis and cleavage of enterovirus polypeptides in mammalian cells. J Virol (1970) 1.73
Factors involved in the generation and replication of rhabdovirus defective T particles. J Virol (1976) 1.72
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol (1976) 1.71
Membrane and nonmembrane proteins of mammalian cells. Synthesis, turnover, and size distribution. Biochemistry (1970) 1.64
Influenza virus effects on cell membrane proteins. Science (1970) 1.62
High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A (1992) 1.60
Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol (1999) 1.60
Cell-mediated immunity to vesicular stomatitis virus infections in mice. Exp Cell Biol (1978) 1.57
Virus-induced interference in heterologously infected HeLa cells. J Virol (1972) 1.57
Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice. Virology (1975) 1.54
Role of defective interfering particles of Sendai virus in persistent infections. Virology (1979) 1.52
Coupled in vitro transcription and translation of vesicular stomatitis virus messenger RNA. Proc Natl Acad Sci U S A (1975) 1.48
High multiplicities of infection favor rapid and random evolution of vesicular stomatitis virus. Virology (1982) 1.47
Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol (1997) 1.45
Carbohydrate composition of the membrane glycoprotein of vesicular stomatitis virus. Virology (1974) 1.42
Virus-directed protein synthesis in different animal and human cells. Science (1968) 1.41
RNA polymerase activity and poly(A) synthesizing activity in defective T particles of vesicular stomatitis virus. Virology (1974) 1.41
Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus? J Virol (1980) 1.34
Properties of DI particle resistant mutants of vesicular stomatitis virus isolated from persistent infections and from undiluted passages. Cell (1983) 1.31
Diversity within natural populations of eastern equine encephalomyelitis virus. Virology (1993) 1.27
Studies on the in vitro transcription and translation of vesicular stomatitis virus mRNA. Virology (1976) 1.26
Vesicular stomatitis virus mutants resistant to defective-interfering particles accumulate stable 5'-terminal and fewer 3'-terminal mutations in a stepwise manner. J Virol (1984) 1.25
Proteinase activity in purified animal viruses. Biochem Biophys Res Commun (1972) 1.21
Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants. Prog Drug Res (1997) 1.21
Denatured DNA as a direct template for in vitro protein synthesis. Proc Natl Acad Sci U S A (1965) 1.21
Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus. Infect Immun (1973) 1.21
Generation of defective interfering particles in picornaviruses. Virology (1980) 1.15
Similarities and differences among specific tRNA's in mammalian tissues. Proc Natl Acad Sci U S A (1967) 1.15
Evolution of fitness in experimental populations of vesicular stomatitis virus. Genetics (1996) 1.11
Natural selection of mutants of vesicular stomatitis virus by cultured cells of Drosophila melanogaster. J Gen Virol (1973) 1.11
Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents. Genet Eng (N Y) (1992) 1.10
Chromatographic differences between tyrosyl transfer RNA from different mammalian cells. Proc Natl Acad Sci U S A (1967) 1.10
Reproducible nonlinear population dynamics and critical points during replicative competitions of RNA virus quasispecies. J Mol Biol (1996) 1.08
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Multiple protein components of mammalian cell membranes. Proc Natl Acad Sci U S A (1968) 1.05
Viruses isolated from cells persistently infected with vesicular stomatitis virus show altered interactions with defective interfering particles. J Virol (1980) 1.05
Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection. J Gen Virol (1986) 1.02
Transcribing complexes in cells infected by vesicular stomatitis virus and rabies virus. J Virol (1974) 1.00
Analysis of virus replication in ageing human fibroblast cultures. Nature (1973) 1.00
Persistent vesicular stomatitis virus infection mediates base substitutions in viral RNA termini. J Virol (1979) 0.99
THE MAMMALIAN CELL-VIRUS RELATIONSHIP : V. SUSCEPTIBILITY AND RESISTANCE OF CELLS IN VITRO TO INFECTION BY COXSACKIE A9 VIRUS. J Exp Med (1960) 0.97
Requirements for DI particle prophylaxis against vesicular stomatitis virus infection in vivo. J Gen Virol (1980) 0.95
A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus. Bull World Health Organ (1975) 0.95
The nucleotide sequence of the 5' terminus of vesicular stomatitis virus RNA. Nucleic Acids Res (1979) 0.94
Stimulation of protein synthesis in vitro by partially degraded ribosomal ribonucleic acid and transfer ribonucleic acid. Biochemistry (1966) 0.93
Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance. J Virol (1996) 0.92
Rapid viral quasispecies evolution: implications for vaccine and drug strategies. Mol Med Today (1995) 0.92
Vesicular stomatitis virus and its defective interfering particles exhibit in vitro transcriptional and replicative competition for purified L-NS polymerase molecules. Virology (1989) 0.89
Size distrbution of polypeptide chains in cells. Nature (1970) 0.88
Analysis of viral and defective-interfering nucleocapsids in acute and persistent infection by rhabdoviruses. J Gen Virol (1982) 0.88
Viral genome synthesis in BHK 21 cells persistently infected with Sendai virus. Virology (1980) 0.88
Genome RNA terminus conservation and diversity among vesiculoviruses. J Virol (1987) 0.87
Single-stranded DNA as a template for in vitro protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 0.87
Defective interfering particles from poliovirus vaccine and vaccine reference strains. Virology (1974) 0.87
Structure and origin of a novel class of defective interfering particle of vesicular stomatitis virus. Nucleic Acids Res (1984) 0.87
Repeated transfer of small RNA virus populations leading to balanced fitness with infrequent stochastic drift. Mol Gen Genet (1996) 0.87
Altered replicase specificity is responsible for resistance to defective interfering particle interference of an Sdi- mutant of vesicular stomatitis virus. J Virol (1988) 0.87
Contingent neutrality in competing viral populations. J Virol (2001) 0.87
A double-blind comparison of 0.25% ropivacaine and 0.25% bupivacaine for extradural analgesia in labour. Br J Anaesth (1996) 0.86
RNA synthesis in BHK 21 cells persistently infected with vesicular stomatitis virus and rabies virus. J Gen Virol (1976) 0.84
The intracellular half-lives of nonreplicating nucleocapsids of DI particles of wild type and mutant strains of vesicular stomatitis virus. Virology (1986) 0.83
A procedure for the rapid, quantitative N-acetylation of amino sugar methyl glycosides. Anal Biochem (1975) 0.82
Cultured mammalian cell deoxyribonucleic acid as a template for in vitro protein synthesis. Biochemistry (1966) 0.82
Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus. J Virol (1980) 0.82
Initiation and completion of mitosis in HeLa cells in the absence of protein synthesis. Curr Mod Biol (1967) 0.81
Behavioral toxicology of volatile organic solvents. I. Methods: acute effects of toluene. J Environ Pathol Toxicol Oncol (1987) 0.81
Very rapid generation/amplification of defective interfering particles by vesicular stomatitis virus variants isolated from persistent infection. J Gen Virol (1986) 0.80